Intramyocardial bone marrow mononuclear cells versus bone marrow–derived and adipose mesenchymal cells in a rat model of dilated cardiomyopathy
- 1 August 2017
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 19 (8) , 947-961
Abstract
No abstract availableKeywords
Funding Information
- Fundación Progreso y Salud, Junta de Andalucia, Spain (PI0191-2010)
This publication has 42 references indexed in Scilit:
- Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived CounterpartsStem Cells Translational Medicine, 2013
- Renal interstitial fibrosisCurrent Opinion in Nephrology and Hypertension, 2012
- Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular DiseaseCell Stem Cell, 2012
- The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) TrialJACC, 2010
- A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow–Derived Progenitor Cell Infusion in Patients With Nonischemic Dilated CardiomyopathyCirculation: Heart Failure, 2009
- IFATS Collection: The Conditioned Media of Adipose Stromal Cells Protect Against Hypoxia-Ischemia-Induced Brain Damage in Neonatal RatsStem Cells, 2009
- Percutaneous Intracoronary Cellular Cardiomyoplasty for Nonischemic Cardiomyopathy: Clinical and Histopathological Results: The First-in-Man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) TrialJACC, 2006
- CD34 + and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart FailureCirculation, 2004
- Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathyThe Journal of Heart and Lung Transplantation, 2004
- A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fractionClinical Immunology and Immunopathology, 1990